Phase 3 eVOLVE-Lung02 Trial of Volrustomig plus Chemotherapy (CT) vs Pembrolizumab plus CT in Metastatic NSCLC With PD-L1 TC <50%

  • Johnson, M. L.; 
  • Arriola, E.; 
  • Kato, T.; 
  • Girard, N.; 
  • Gadgeel, S.; 
  • 외 9명
Citations

WEB OF SCIENCE

0
제목
Phase 3 eVOLVE-Lung02 Trial of Volrustomig plus Chemotherapy (CT) vs Pembrolizumab plus CT in Metastatic NSCLC With PD-L1 TC <50%
저자
Johnson, M. L.; Arriola, E.; Kato, T.; Girard, N.; Gadgeel, S.; Tarruella, M. Majem; Newsom-Davis, T.; Polaczek, M.; Chen, X.; Stefaniak, K.; Lowery, C.; Angra, N.; Doherty, G.; Ahn, M-j.
발행일
2025-10
유형
Meeting Abstract
저널명
Journal of Thoracic Oncology
권
20
호
10